NT5E Recombinant Monoclonal Antibody

Code: CSB-RA723415MA1HU

Rate （N/A）
Review （0）

Size:

50μl100μl

US$210

Quantity:

Species Reactivity: Human

Application: ELISA, IHC, FC

Send an Inquiry

Start an on-line Chat

Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details
Related Products
Customer Reviews and Q&A
Target Background

Product Details

Uniprot NO.

P21589

Target Names

NT5E

Alternative Names

5' NT antibody; 5' nucleotidase (CD73) antibody; 5' nucleotidase precursor antibody; 5' nucleotidase; ecto antibody; 5' nucleotidase; ecto (CD73) antibody; 5'-NT antibody; 5'-nucleotidase antibody; 5NTD_HUMAN antibody; CD73 antibody; CD73 antigen antibody; E5NT antibody; Ecto 5' nucleotidase antibody; Ecto-5'-nucleotidase antibody; eN antibody; eNT antibody; NT antibody; NT5 antibody; NT5E antibody; NTE antibody; Purine 5 Prime Nucleotidase antibody

Species Reactivity

Human

Immunogen

Recombinant Human NT5E protein

Conjugate

Non-conjugated

Clonality

Monoclonal

Isotype

hIgG1

Clone No.

8G5

Purification Method

Affinity-chromatography

Concentration

It differs from different batches. Please contact us to confirm it.

Buffer

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Form

Liquid
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Scope Application

ELISA Protocol Immunohistochemistry (IHC) Protocol Flow Cytometry (FC) Protocol

Recommended Dilution

Application	Recommended Dilution
IHC	1:50-1:200
FC	1:50-1:200

Storage

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Lead Time

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.

Usage

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

Datasheet & COA

Antibody FAQs

Images

Overlay Peak curve showing PC3 cells surface stained with CSB-RA723415MA1HU (red line) at 1:100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10⁶cells) for 45min at 4℃. The secondary antibody used was FITC-conjugated Goat Anti-human IgG(H+L) at 1:200 dilution for 35min at 4℃.Control antibody (green line) was mouse IgG (1ug/1*10⁶cells) used under the same conditions. Acquisition of >10,000 events was performed.

Description

NT5E, also known as CD73 or ecto-5'-nucleotidase, serves as a critical enzyme in purine metabolism and adenosine signaling pathways. This glycosylphosphatidylinositol-anchored membrane protein catalyzes the conversion of extracellular AMP to adenosine, playing essential roles in cardiovascular physiology, immune regulation, and tissue homeostasis. In cardiovascular research, NT5E-generated adenosine influences vascular tone, platelet aggregation, and cardioprotective responses during ischemic events, making this target particularly valuable for investigators studying heart disease and vascular biology.

This recombinant monoclonal antibody, clone 8G5, offers the reproducibility and consistency that demanding research applications require. Produced using recombinant technology with a defined sequence, this antibody eliminates the lot-to-lot variability often encountered with traditional hybridoma-derived reagents. The human IgG1 format and affinity chromatography purification ensure high specificity for human NT5E, providing reliable performance across extended studies where experimental consistency is paramount.

Validation studies confirm this antibody's utility in multiple experimental workflows. Flow cytometry analysis using PC3 cells demonstrates clear surface detection of NT5E, with distinct separation between antibody-stained and isotype control populations when used at 1:100 dilution. This validated performance extends to immunohistochemistry applications at dilutions ranging from 1:50 to 1:200, enabling researchers to examine NT5E expression patterns in tissue sections. ELISA compatibility further expands experimental options for quantitative assessments.

For cardiovascular researchers investigating adenosine-mediated signaling, endothelial function, or immune cell regulation, this NT5E antibody provides a dependable tool for characterizing CD73 expression and distribution in human samples across multiple detection platforms.

Customer Reviews and Q&A

■ Customer Reviews

Submit a Review here

Target Background

Function(From Uniprot)

Hydrolyzes extracellular nucleotides into membrane permeable nucleosides. Exhibits AMP-, NAD-, and NMN-nucleosidase activities.

Gene References into Functions

Changes in the local expression and activity of CD39 and CD73 in calcified valves suggest their potential role in calcific aortic valve disease. PMID:30056298
High expression of NT5E is associated with Prostate Cancer. PMID:29916747
Case Report: identify novel mutations in the NT5E gene in patient with calcification of joints and arteries. PMID:28825389
High CD73 expression is associated with breast cancer. PMID:29047106
High CD73 expression is associated with neoplasms. PMID:29514610
NT5E-targeting miRNAs (miR-30b and miR-340) function as tumor suppressors PMID:29155108
soluble CD73 might be used as serologic prognostic biomarker in patients with metastatic melanoma patients. PMID:29202855
High CD73 expression is associated with the increase in the ability of surviving breast cancer cells to evade innate and adaptive immunity. PMID:29367423
analysis of how inhibitors block human CD73 and block efficiently its enzymatic function in the low micromolar range through a non-competitive inhibition mechanism PMID:29377887
The Ecto-5'nucleotidase, together with alkaline phosphatase, also expressed apically in oviductal epithelium, complete the hydrolysis sequence by dephosphorylating AMP to adenosine. PMID:29273916
this paper shows that simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro PMID:28389406
high levels of CD73 are significantly associated with reduced overall survival in patients with head and neck squamous cell carcinoma PMID:27557512
Studied role of miR-30a in colorectal cancer(CRC). Found miR-30a is downregulated in CRC, and it inhibits cell proliferation in CRC by reducing expression of CD73. PMID:28464916
we demonstrated the existence of CSCs in both cultured ccRCC cell line and tissues, and CD73 as a cell-surface biomarker for ccRCC CSC-like cells. PMID:28404888
Induction of ecto-5'-nucleotidase/CD73 by radiation contributes to the radiosensitivity of T24 urinary bladder cancer cell line. PMID:29305710
Report prognostic impact of CD73 expression in non-small lung cancers. PMID:28060732
Data show that MiR-422a and its target CD73 are involved in early loco(regional) recurrence of head and neck squamous cell carcinoma (HNSCC) tumors and are targets for personalized medicine. PMID:27281619
HPV+ cervical cancer cells express higher levels of CD73 than HPV- cells, and this expression is associated with the production of larger amounts of adenosine, as well as a stronger inhibition of proliferation, activation, and cytotoxic activity of CD8+ T cells via interaction with A2A adenosine receptor PMID:28950987
High CD73 expression is associated with Melanoma Metastasis. PMID:28652244
Hippocampal astrogliosis observed in medial temporal lobe epilepsy patients was accompanied by a proportionate increase in A2A receptor and ecto-5'-nucleotidase/CD73 immunoreactivities. PMID:27650530
High CD73 expression is associated with cervical cancer. PMID:28202050
Endogenous Plastic Somatic (ePS) cells in a latent state, i.e. lacking SOX2, OCT3/4 and NANOG (SON) expression, in non-diseased breast specimens through immunohistochemical analysis of previously identified ePS-specific biomarkers (CD73(+), EpCAM(+) and CD90(-)). PMID:27705752
Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. PMID:28193736
CD73 polymorphisms play a role in calciphylaxis development in dialysis patients. PMID:28212442
CD73 expression is upregulated in NSCLC and is correlated with a decrease in miR-30a-5p expression. PMID:28158983
This study found that in septic critically ill patients the soluble CD73 levels were generally low and showed a further decrease from 0h to 24h. Moreover, the sCD73 levels were higher in acute kidney injury (AKI) versus non-AKI patients and in non-survivors with severe sepsis than in survivors, but were not independently associated either with the development of AKI or 90-day mortal PMID:27732656
concluded that CD39 and CD73 are molecular targets for the development of drugs for ALF patients care PMID:27899277
Genetic polymorphism of NT5E may contribute to the pathogenesis of calcific aortic valve disease. PMID:27906615
Oxidized low density lipoproteins modulate CD39 and CD73 activity in the endothelium. PMID:27906627
CD73 may play an important role in breast cancer stem cells. PMID:27670764
This study aimed to investigate the activities of purinergic system ecto-enzymes present on the platelet surface as well as CD39 and CD73 expressions on platelets of sickle cell anemia treated patients. PMID:27044834
Aim of the present study was to investigate the role of CD73 in glioma blood vessels; results found that the expression of CD73 in glioma vascular cells is significantly decreased, and this reduction may down-regulate the expression of brain microvascular endothelial tight junction-related proteins PMID:26884147
These results provide a finely mapped epitope that can be targeted for selective, potent, and non-competitive inhibition of CD73, as well as establish a strategy for inhibiting enzymes that function in both membrane-bound and soluble states. PMID:26854859
CD73 promotes the growth of human colorectal cancer cells through EGFR and the b-catenin/cyclin D1 signaling pathway. CD73 may be used as a valuable biomarker of colorectal cancer. PMID:26708311
Our study revealed that CD73 is an independent prognostic factor in prostate cancer. PMID:26253870
The NT5E gene is involved in both intrinsic and acquired resistance to platinum-based drugs in ovarian cancer. [meta-analysis] PMID:26629888
CD73 expression was significantly correlated with the invasion into adjacent organs. PMID:26691441
report on a Chinese family with CALJA and novel compound heterozygous mutations (c.1360G>A (p.Gly454Arg) and c.1387C>T (p.Arg463X)) in NT5E PMID:26178434
findings reveal that CD73-generated adenosine promotes epithelial integrity and suggest why loss of CD73 in endometrial cancer allows for tumor progression PMID:26642367
CD73 activity from any host cell type is not required for the monocyte/macrophage polarization in the peritoneum towards a pro- or an anti-inflammatory phenotype in vivo PMID:26258883
these data suggest a possible role for CD73 and A2A in inflammation observed in patients with T2D and obesity mediated via apoptosis. PMID:25770019
This study highlights a role for CD73 as a prognostic marker of patient survival and also as a candidate therapeutic target in high-grade serous ovarian cancers. PMID:26363007
role of CD73 and CD39 ectonucleotidases in T cell differentiation PMID:26226423
Expression of NPP1 and 5'-nucleotidase by valve interstitial cells promotes the mineralization of the aortic valve through A2aR and a cAMP/PKA/CREB pathway. PMID:25644539
Although upregulated CD73 expression in tumor cells correlates with a poor prognosis in patients with rectal adenocarcinoma, the combination of CD73 expression in malignant epithelial cells and tumor stroma may have a better prognostic value PMID:25677906
rs9444348 heterozygosity is associated with increased risk of post-traumatic epilepsy development after brain injury. PMID:26040919
Species-specific CD73 regulation, with potential significance to cancer, fibrosis, and other diseases characterized by changes in CD73 expression and function. PMID:25298403
The Nt5e(-/-) targeted mutant mice recapitulate some, but not all, features of ACDC and serve as a model system to study pharmacologic interventions for ectopic mineralization. PMID:25486201
CD73 enhances endothelial barrier function and sprouting in blood but not lymphatic vasculature. PMID:25402681
It decompose ATP and produce adenosine, which regulates immunity via adenosine receptor. PMID:25675814